about
Genomic screening with RNAi: results and challengesMicroRNAS in endometrial cancer: recent advances and potential clinical applicationsEmerging therapeutic biomarkers in endometrial cancerThe pursuit of oncotargets through understanding defective cell regulationReducing tumor growth and angiogenesis using a triple therapy measured with Contrast-enhanced ultrasound (CEUS)Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesisThe siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapyMicroRNAs as biomarkers in colorectal cancerKnockdown of Ki-67 by dicer-substrate small interfering RNA sensitizes bladder cancer cells to curcumin-induced tumor inhibition.Kinetics and Mechanisms of Oxidative Cleavage of HIV RRE RNA by Rev-Coupled Transition Metal ChelatesApoptosis induced by a HIPK2 full-length-specific siRNA is due to off-target effects rather than prevalence of HIPK2-Δe8 isoform.In vivo delivery of miRNAs for cancer therapy: challenges and strategies.Matrix metalloproteinase and G protein coupled receptors: co-conspirators in the pathogenesis of autoimmune disease and cancer.Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC.Chemosensitization of prostate cancer by modulating Bcl-2 family proteins.Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression.Oncolytic-adenovirus-expressed RNA interference for cancer therapy.Potential use of RNA interference in cancer therapy.Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.Translational Approaches towards Cancer Gene Therapy: Hurdles and Hopes.Small Players Ruling the Hard Game: siRNA in Bone Regeneration.Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells.Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis.Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer.Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy.Gold nanoparticle-siRNA mediated oncogene knockdown at RNA and protein level, with associated gene effects.Evaluation of ERCC1 expression for cisplatin sensitivity in human hepatocellular carcinoma.Intelligent nucleic acid delivery systems based on stimuli-responsive polymers
P2860
Q24626537-1EADD83A-34DA-4670-A826-EE6FD1E7BFC7Q26780358-AE8EEBB8-E337-4BB1-BE5E-D3B84FD338DEQ26865904-5D1A9523-0743-4FAD-AB35-6ACEA9607B46Q28395166-1402817F-1DFD-4531-BBC4-9B5B055D2FE4Q30411344-F90F2FED-7F59-411C-8BB1-09696E97608EQ33539986-FA637E5A-06F1-4FD2-8139-26ECC9E0E68FQ33578222-A77D1C45-C5C4-4DF7-B273-3A721574E44AQ34162262-B4A357C0-6DB2-4F6B-B7E5-5B7E59114056Q34477376-FB935491-EE68-4716-9567-5D2F7F1E710CQ34693492-3E306CB9-6B10-44C6-ADFD-439FF33F96D8Q36738933-03B50BF6-5FC2-40B3-9795-1B96D328606FQ37228217-8FE6D975-CF04-4680-91B8-BC2098AE0BD3Q37439490-15532D3B-D770-428A-8CE5-41E697140FD9Q37478042-89E1CD15-3635-43C3-B455-FE6B089AB430Q37713757-31806A82-DE81-44E5-8125-A1CAF0887E6BQ37725631-29C8D36F-ADF5-4BEF-A0BA-D11A0AD05CE4Q37777745-00CA6E31-7230-49EC-9383-27ABCD29799FQ37780603-D9EB4330-E713-4F4F-904E-06292FD3D03EQ38037048-567C0DBC-9F9A-4DD5-967D-349CDC2D0021Q38107203-7F308D8A-B255-4806-9A2E-2677DB175962Q38738927-DC3BAB32-10BD-4502-9A49-6B218DF60AF0Q38756973-85B655F1-BC78-43EA-B3A9-E2857635ABB3Q39361870-022CD2E9-2EC4-49C4-B790-010041D5CA39Q39583104-A7E9D6D2-60C8-4690-9987-5FFF2715B288Q39741953-89B4568B-5E88-48D5-B59D-698BED81747BQ51797664-D5CC0E33-4DAD-4161-B0BE-8F1F8E0645F8Q53289466-8D91A2DA-A9D5-44A9-828E-7E5928FF433FQ57363419-1560F473-6AE9-42FC-8DFC-83EECBDC5EA7
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Concepts in in vivo siRNA delivery for cancer therapy.
@en
Concepts in in vivo siRNA delivery for cancer therapy.
@nl
type
label
Concepts in in vivo siRNA delivery for cancer therapy.
@en
Concepts in in vivo siRNA delivery for cancer therapy.
@nl
prefLabel
Concepts in in vivo siRNA delivery for cancer therapy.
@en
Concepts in in vivo siRNA delivery for cancer therapy.
@nl
P2860
P356
P1476
Concepts in in vivo siRNA delivery for cancer therapy.
@en
P2093
Jasti S Rao
P2860
P304
P356
10.1002/JCP.21790
P577
2009-08-01T00:00:00Z